KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
| Catalog Number | YR1447 |
|---|---|
| Product Name | Anti-Human CD3E & CD123 Recombinant Antibody |
| Molecular Name | Flotetuzumab |
| Alias | Anti-CD3E & CD123 Recombinant Antibody, Research Grade Flotetuzumab |
| CAS Number | 1664355-28-5 |
| Target | CD3E & CD123[Homo sapiens] |
| Isotype | VH-VL-VH'-VL' |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Background | Flotetuzumab (INN, development code MGD006) is a bispecific antibody designed for the treatment of acute myeloid leukemia. This drug is being developed by MacroGenics, Inc. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
Hot Line： +1-315-239-3085
Technical Support：[email protected]
